查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604709

輔助生殖技術市場：按類型、診斷、最終用戶分類 - 全球預測 2025-2030

Assisted Reproductive Technology Market (ART) by Type (Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer), Diagnosis (Genetic Testing, Hormone Testing, Hysterosalpingography), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年輔助生殖技術市場價值為251.2億美元，預計到2024年將達到295.2億美元，複合年成長率為17.57%，到2030年將達到780.4億美元。

輔助生殖技術 (ART) 包括解決不孕症的醫療程序，例如體外受精 (IVF)、人工授精和冷凍保存。由於生活方式的改變、人口老化以及卵巢症候群等疾病的增加，導致不孕率上升，因此需要輔助生殖技術。輔助生殖技術應用於診所和醫院，幫助個人和夫婦懷孕，主要是為試圖克服不孕症的各種挑戰的家庭。最終使用領域主要是醫療機構和生育中心。醫療技術的進步、不孕症治療意識的提高以及不同人群對 ART 治療接受度的提高推動了 ART 市場的發展。此外，許多地區的政府支持和有利的法規也有助於市場擴張。關鍵的商機來自於提高手術成功率的人工智慧和機器學習演算法等技術創新，以及不孕症治療需求不斷增加的新興市場的服務擴展。然而，挑戰包括成本高、道德問題、准入有限，以及某些地區缺乏熟練的專業人員。此外，社會和文化偏見也會阻礙採用率。未來的創新可能會集中在提高手術成功率、降低成本以及透過基因圖譜進行個人化治療和改善患者體驗。研究和開發的重要領域包括非侵入性診斷工具、改進的胚胎選擇方法和荷爾蒙療法替代方案。對於業務成長而言，將服務擴展到新興市場並投資遠端醫療進行初步諮詢可能是有益的。由於技術進步和不孕症盛行率的增加，輔助生殖技術市場充滿活力，並具有巨大的成長潛力。然而，克服道德、文化和成本挑戰對於持續成功至關重要。

主要市場統計
基準年[2023] 251.2億美元
預計年份 [2024] 295.2億美元
預測年份 [2030] 780.4億美元
複合年成長率（%） 17.57%

市場動態：揭示快速發展的輔助生殖技術市場的關鍵市場洞察

供需的動態交互作用正在改變輔助生殖技術市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於壓力、污染和肥胖導致不孕症患者數量不斷增加
    • 新興國家醫療保健支出增加
    • 卵巢癌、子宮內膜癌和多囊性卵巢症候群的發生率增加
  • 市場限制因素
    • 手術費用高，成功率低。
  • 市場機會
    • 努力提高政府和公共機構的認知
    • 減少治療併發症的技術進步
  • 市場挑戰
    • 新興經濟體缺乏先進的基礎設施

波特五力：駕馭輔助生殖科技市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解輔助生殖技術市場的外部影響

外部宏觀環境因素在塑造輔助生殖技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解輔助生殖技術市場的競爭狀況

對輔助生殖技術市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣輔助生殖技術市場供應商績效評估

FPNV定位矩陣是評估輔助生殖技術市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃輔助生殖技術市場的成功之路

輔助生殖技術市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於壓力、污染和肥胖導致的不孕率增加
      • 新興國家醫療保健費用上漲
      • 卵巢癌、子宮內膜癌和卵巢症候群（PCOS）的發生率增加
    • 抑制因素
      • 該手術費用昂貴且成功率低。
    • 機會
      • 政府和公共機構為意識提升所做的努力
      • 減少治療併發症的技術進步
    • 任務
      • 新興經濟體缺乏先進的基礎設施
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章輔助生殖科技市場：依類型

  • 人工授精
  • 供體受精
  • 配子輸卵管植入
  • 體外受精
  • 誘導排卵
  • 代孕

第7章 診斷輔助生殖技術市場

  • 基因檢測
  • 荷爾蒙測試
  • 造影
  • 影像檢查
  • 卵巢儲備測試
  • 排卵測試

第8章輔助生殖科技市場：依最終使用者分類

  • 診所
  • 婦科中心
  • 醫院
  • 體外受精中心

第9章美洲輔助生殖技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區輔助生殖技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲輔助生殖科技市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Carl Zeiss AG
  • CCB Kitazato, LLC
  • CooperSurgical, Inc. Cooper Companies Inc.
  • Cryolab Ltd.
  • Esco Micro Pte. Ltd.Esco Lifesciences Group
  • Ferring BV
  • FUJIFILM Irvine Scientific, Inc.
  • Genea Limited
  • INVO Bioscience
  • Merck & Co., Inc.
  • Nidacon International AB
  • Planer PLC by Hamilton Thorne, Inc.
  • Rocket Medical plc by Roko AB
  • Thermo Fisher Scientific company
  • Vitrolife AB
Product Code: MRR-436901065A94

The Assisted Reproductive Technology Market was valued at USD 25.12 billion in 2023, expected to reach USD 29.52 billion in 2024, and is projected to grow at a CAGR of 17.57%, to USD 78.04 billion by 2030.

Assisted Reproductive Technology (ART) encompasses medical procedures used to address infertility, including in vitro fertilization (IVF), artificial insemination, and cryopreservation. The necessity of ART stems from rising infertility rates due to lifestyle changes, aging populations, and increased incidences of medical conditions like polycystic ovary syndrome. It is applied in clinics and hospitals to help individuals and couples conceive, catering primarily to families seeking to overcome various fertility challenges. The end-use sectors are primarily healthcare facilities and fertility centers. The market for ART is driven by advancements in medical technologies, growing awareness about fertility treatments, and increasing acceptance of ART procedures across various demographics. Additionally, governmental support and favorable regulations in many regions are contributing to market expansion. Key opportunities arise from technological innovations, such as AI and machine learning algorithms that enhance procedure success rates, and expanding services in emerging markets where fertility treatment demand is rising. However, challenges include high costs, ethical concerns, and limited access in certain regions, alongside a lack of skilled professionals in some areas. Additionally, societal and cultural stigmas can hinder adoption rates. Future innovations could focus on improving technique success rates, reducing costs, and personalizing treatments through genetic mapping and enhanced patient experience. Critical areas ripe for research and development include non-invasive diagnostic tools, improved embryo selection methods, and hormone therapy alternatives. For business growth, expanding services to emerging markets and investing in telehealth for initial consultations could prove beneficial. The ART market is dynamic, with significant growth potential, driven by technological advancements and the increasing prevalence of infertility. However, navigating ethical, cultural, and cost-related challenges will be crucial for sustained success.

KEY MARKET STATISTICS
Base Year [2023] USD 25.12 billion
Estimated Year [2024] USD 29.52 billion
Forecast Year [2030] USD 78.04 billion
CAGR (%) 17.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Assisted Reproductive Technology Market

The Assisted Reproductive Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of infertility cases due to stress, pollution, and obesity
    • Rising healthcare expenditure across emerging nations
    • Increasing prevalence of ovarian & endometrial cancer and PCOS issues
  • Market Restraints
    • High cost required for the procedure and lower success rate
  • Market Opportunities
    • Initiatives from government and public organizations to increase awareness
    • Technological advancements to reduce the treatment complications
  • Market Challenges
    • Dearth of advanced infrastructure in developing economies

Porter's Five Forces: A Strategic Tool for Navigating the Assisted Reproductive Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Assisted Reproductive Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Assisted Reproductive Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Assisted Reproductive Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Assisted Reproductive Technology Market

A detailed market share analysis in the Assisted Reproductive Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Assisted Reproductive Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Assisted Reproductive Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Assisted Reproductive Technology Market

A strategic analysis of the Assisted Reproductive Technology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Assisted Reproductive Technology Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss AG, CCB Kitazato, LLC, CooperSurgical, Inc. Cooper Companies Inc., Cryolab Ltd., Esco Micro Pte. Ltd.Esco Lifesciences Group, Ferring B.V., FUJIFILM Irvine Scientific, Inc., Genea Limited, INVO Bioscience, Merck & Co., Inc., Nidacon International AB, Planer PLC by Hamilton Thorne, Inc., Rocket Medical plc by Roko AB, Thermo Fisher Scientific company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Assisted Reproductive Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer, In Vitro Fertilization, Ovulation Induction, and Surrogacy.
  • Based on Diagnosis, market is studied across Genetic Testing, Hormone Testing, Hysterosalpingography, Imaging Testing, Ovarian Reserve Testing, and Ovulation Testing.
  • Based on End User, market is studied across Clinics, Gynecology Centers, Hospitals, and In Vitro Fertilisation Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of infertility cases due to stress, pollution, and obesity
      • 5.1.1.2. Rising healthcare expenditure across emerging nations
      • 5.1.1.3. Increasing prevalence of ovarian & endometrial cancer and PCOS issues
    • 5.1.2. Restraints
      • 5.1.2.1. High cost required for the procedure and lower success rate
    • 5.1.3. Opportunities
      • 5.1.3.1. Initiatives from government and public organizations to increase awareness
      • 5.1.3.2. Technological advancements to reduce the treatment complications
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of advanced infrastructure in developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Assisted Reproductive Technology Market, by Type

  • 6.1. Introduction
  • 6.2. Artificial Insemination
  • 6.3. Donor Conception
  • 6.4. Gamete Intrafallopian Transfer
  • 6.5. In Vitro Fertilization
  • 6.6. Ovulation Induction
  • 6.7. Surrogacy

7. Assisted Reproductive Technology Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. Genetic Testing
  • 7.3. Hormone Testing
  • 7.4. Hysterosalpingography
  • 7.5. Imaging Testing
  • 7.6. Ovarian Reserve Testing
  • 7.7. Ovulation Testing

8. Assisted Reproductive Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Gynecology Centers
  • 8.4. Hospitals
  • 8.5. In Vitro Fertilisation Centers

9. Americas Assisted Reproductive Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Assisted Reproductive Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Assisted Reproductive Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Carl Zeiss AG
  • 2. CCB Kitazato, LLC
  • 3. CooperSurgical, Inc. Cooper Companies Inc.
  • 4. Cryolab Ltd.
  • 5. Esco Micro Pte. Ltd.Esco Lifesciences Group
  • 6. Ferring B.V.
  • 7. FUJIFILM Irvine Scientific, Inc.
  • 8. Genea Limited
  • 9. INVO Bioscience
  • 10. Merck & Co., Inc.
  • 11. Nidacon International AB
  • 12. Planer PLC by Hamilton Thorne, Inc.
  • 13. Rocket Medical plc by Roko AB
  • 14. Thermo Fisher Scientific company
  • 15. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DONOR CONCEPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HORMONE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IMAGING TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVARIAN RESERVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILISATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 154. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023